Symposium to discuss global harmonization of vaccine testing requirements

Human Toxicology Project Consortium partner Humane Society International will present a symposium on Global Harmonization of Vaccine Testing on March 19, 2019, in Rome. This event will bring together experts to discuss the elimination of abnormal toxicity tests and target animal batch safety tests for batch release of biologicals and immunologicals for human and veterinary use, a milestone that has been achieved in some regions. A key goal of the symposium is to explore barriers faced in regions still using these tests and what kind of actions should be taken or suggested to achieve elimination of these tests worldwide. A detailed overview of the symposium is available here. For more information, contact Laura Viviani at lviviani@hsi.org.

HSI HTPC partners vaccine testing

China developing a roadmap to twenty-first century toxicity testing

At a special symposium last month in Xi’an, China, participants began to map China’s regulatory steps toward twenty-first century toxicology and away from animal testing.

The symposium, “TT21C/AOP China Roadmap,” was part of a conference on alternatives to animal tests in toxicology that was hosted by the Chinese Society of Toxicology’s Committee on Toxicological Alternatives and Translational Toxicology and the Chinese Environment Mutagen Society’s Committee on Toxicity Testing and Alternative Methods, and co-sponsored by the Humane Society International (HSI), Unilever, L’Oreal, and Shell. The symposium was convened “to address the need to increase Chinese regulatory uptake of currently available alternatives and the AOP paradigm.” Human Toxicology Project Consortium coordinator Dr. Catherine Willett was an invited speaker (a PDF of her presentation, “Use of Adverse Outcome Pathways (AOPs) to Reduce Uncertainty and Animal Use in Chemical Hazard and Risk Assessment,” is available).

During the symposium, a working team comprised of members from the host societies and representatives from Unilever, L’Oreal, HSI, and others was established to begin working on the twenty-first century toxicology “roadmap.” Asked about the team’s next steps in a Chemical Watch article (subscription required) about the symposium, Dr. Carl Westmoreland (Director of Science and Technology at Unilever’s Safety and Environmental Assurance Centre, and a member of the working team) said the host committees will prepare a summary of the proceedings and circulate it to participants for review.

alternative toxicity testing AOPs HSI HTPC members in the news L'Oreal Meetings & Events pathway-based approaches Unilever